Matthew L. Kaplan - 12 Jun 2025 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Role: Director
Signature: /s/ Matthew Kaplan
Issuer symbol: NVCT
Transactions as of: 12 Jun 2025
Net transactions value: $0
Form type: 4
Filing time: 12 Jun 2025, 16:31:16 UTC
Previous filing: 13 Jun 2024
Next filing: 06 Nov 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Kaplan Matthew L.	Director	C/O NUVECTIS PHARMA, INC.,, 1 BRIDGE PLAZA, SUITE 275, FORT LEE	/s/ Matthew Kaplan	12 Jun 2025	0001895952

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NVCT	Common Stock	Award	$0	+30,000	+36%	$0.000000	113,760	12 Jun 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The 30,000 shares of restricted Common Stock will vest in equal annual installments over three years beginning on the first anniversary of the grant date subject to Mr. Kaplan's continued service on the Company's Board of Directors on such dates.